Smithfield Trust Co’s Johnson & Johnson Position
Does Smithfield Trust Co own Johnson & Johnson (JNJ)? Yes — 79.9K shares worth $20M (+0.85% of its 13F portfolio) as of Q1 2026, down from 80.1K shares the prior filed quarter.
Position Value
$20M
Q1 2026
Shares
79.9K
% of Portfolio
+0.85%
Quarters Held
30
currently held
Position History JNJ
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 79.9K | $20M | +0.85% |
| Q4 2025 | 80.1K | $17M | +0.73% |
| Q3 2025 | 79.5K | $15M | +0.66% |
| Q2 2025 | 79.7K | $12M | +0.58% |
| Q1 2025 | 80.2K | $13M | +0.67% |
| Q4 2024 | 84.5K | $12M | +0.61% |
| Q3 2024 | 86.5K | $14M | +0.69% |
| Q2 2024 | 82.2K | $12M | +0.63% |
| Q1 2024 | 83.2K | $13M | +0.70% |
| Q4 2023 | 85.9K | $13M | +0.76% |
| Q3 2023 | 87.6K | $14M | +0.84% |
| Q2 2023 | 87.6K | $14M | +0.88% |
| Q1 2023 | 88.7K | $14M | +0.88% |
| Q4 2022 | 89.3K | $16M | +1.06% |
| Q3 2022 | 90.0K | $15M | +1.06% |
| Q2 2022 | 90.7K | $16M | +1.13% |
| Q1 2022 | 90.7K | $16M | +1.04% |
| Q4 2021 | 90.5K | $16M | +0.96% |
| Q3 2021 | 91.8K | $15M | +0.98% |
| Q2 2021 | 91.9K | $15M | +1.00% |
| Q1 2021 | 91.6K | $15M | +1.04% |
| Q4 2020 | 91.9K | $14M | +1.05% |
| Q3 2020 | 92.5K | $14M | +1.12% |
| Q2 2020 | 81.5K | $11M | +1.03% |
| Q1 2020 | 80.2K | $11M | +1.10% |
| Q4 2019 | 83.1K | $12M | +1.13% |
| Q3 2019 | 85.9K | $11M | +1.10% |
| Q2 2019 | 85.9K | $12M | +1.24% |
| Q1 2019 | 80.5K | $11M | +1.22% |
| Q4 2018 | 82.2K | $11M | +1.24% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Smithfield Trust Co’s full portfolio or all institutional holders of JNJ.